Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                MCMi Professional Development Activities

MCMi Professional Development Activities

                        About MCMi Professional Development
          Training Course: Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens
          Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories Home
          Emergency Preparedness and Response
          Counterterrorism and Emerging Threats
          Medical Countermeasures Initiative (MCMi)
          MCMi Professional Development Activities
          About MCMi Professional DevelopmentMCMi Professional Development Activities About MCMi Professional Development
  
  					Through professional development, FDA meets the regulatory challenges posed by new science and technology developments.
	
    Subscribe to Email Updates
    Share
    Post
    Linkedin

    Email
    PrintImage
              A participant in a data quality course conducts a training exercise wearing BSL-4 personal protective equipment.


  Caption
        
      A participant in an MCMi-sponsored data quality course conducts a training exercise wearing BSL-4 personal protective equipment.Through professional development, FDA meets the regulatory challenges posed by new science and technology developments. In addition to supporting a broad regulatory science program—including professional development components—FDA fosters collaborative activities with scientific institutions, academia, and industry.

Lectures, training courses and symposia

The FDA Medical Countermeasures Initiative (MCMi) supports lectures that cover a range of topics including guidance development, the policies, procedures, and framework for assessing applications for review, and other timely medical countermeasure (MCM)-related topics. Lectures include:

Foundations for Preclinical Review

Lecture series to engage subject matter experts from FDA Centers and offices on issues related to obtaining valid, reliable animal models for human disease. Goals include examining common study pitfalls and supporting consistent guidance development.

MCMi Lecture Series

Periodic presentations to broaden understanding of the policies, procedures, and U.S. governmental framework for FDA reviewers assessing applications for medical products to counter chemical, biological, radiological, and nuclear (CBRN) threats and emerging infectious diseases.

Training course: Achieving Data Quality and Integrity in Maximum Containment Laboratories (Bethesda, MD)

To help address the challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and the University of Texas Medical Branch, Galveston National Laboratory (UTMB) collaborate to provide a week-long **annual training course**on how to meet GLP requirements in BSL-4 facilities.

Training Course: Achieving Data Quality and Integrity in Clinical Trials Involving High Consequence Pathogens

This **annual course**, hosted by FDA and UTMB, focuses on the preparation and execution of research clinical trials to facilitate the approval of MCMs for high-consequence pathogens.

MCMi Regulatory Science Symposium

For several years (2012-2014), MCMi sponsored an annual regulatory science symposium [ARCHIVED] to exchange ideas on MCM development and explore the latest research. Webcast recordings are available. In 2015, in lieu of a separate MCMi symposium, FDA began hosting a more comprehensive FDA Science Forum to discuss a wide variety of topics, including medical countermeasure-related research.

FDA Science Forum

Every two years, FDA hosts the FDA Science Forum, featuring an opportunity for the public to view the unique scientific research and collaborative efforts of FDA’s 11,000 scientists across a wide range of disciplines. Sessions include updates on medical countermeasures, infectious disease, pathogen reduction technologies, novel technologies, product development, manufacturing, and more.

Advancing skills of FDA staff with continuing education

The Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA) contains key legal authorities to sustain and strengthen our Nation's preparedness for public health emergencies involving chemical, biological, radiological, and nuclear (CBRN) agents, as well as emerging infectious disease threats. PAHPRA provisions focusing on FDA's interactions with government and industry working to develop MCMs help ensure that FDA personnel involved in review of applications for MCMs have sufficient background information, training, and expertise.

FDA recruits and fosters top talent by providing innovative skill development programs to prepare staff to successfully address the regulatory challenges presented by new areas of science and medicine. MCMi offers continuing education credits to physicians, nurses, pharmacists, and veterinarians who attend selected professional development activities.

FDA hosts numerous public meetings and workshops each year. For MCM-related events, visit our News and Events page.

                                                                                  Content current as of:
      04/28/2023
              
              
Topic(s)
			  Training & Education
				    				       				    				       EmergenciesLaw(s) & Regulation(s)
			  Pandemic and All-Hazards Preparedness Reauthorization Act of 2013 (PAHPRA)MCMi Professional Development Activities

          
                        About MCMi Professional Development
          Training Course: Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens
          Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories
 Subscribe
                        Sign up to receive email alerts on emergency preparedness and response topics from FDA, including new professional development opportunities.
    Enter your email address to subscribe:
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop